Evidence map›Paper›PMID 39545079›Full record

ReviewBioengineering & translational medicine2024

Hydrogels in the clinic: An update.

John R Clegg, Kolade Adebowale, Zongmin Zhao, Samir Mitragotri

Abstract readReview
In one paragraph

Review in Bioengineering & translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John R CleggStephenson School of Biomedical Engineering University of Oklahoma Norman Oklahoma USA.
Kolade AdebowaleJohn A. Paulson School of Engineering and Applied Sciences Harvard University Allston Massachusetts USA.
Zongmin ZhaoDepartment of Pharmaceutical Sciences, College of Pharmacy University of Illinois at Chicago Chicago Illinois USA.ORCID https://orcid.org/0000-0001-8979-844X
Samir MitragotriJohn A. Paulson School of Engineering and Applied Sciences Harvard University Allston Massachusetts USA.ORCID https://orcid.org/0000-0002-2459-8305

Funding

Enabled by drug delivery: Studying the role of brain-resident and infiltrating myeloid cell phenotype in brain damage associated with inflammatory diseaseR35GM150970 · NIGMS · UNIVERSITY OF OKLAHOMA · PI John R Clegg · 2023 to 2026
$1.7M
BIOPHYSICAL CUES SHAPING MACROPHAGE AND T-CELL FUNCTIONSK99GM151568 · NIGMS · HARVARD UNIVERSITY · PI ADEBOWALE, KOLADE · 2023 to 2024
$250k
NIGMS NIH HHS K99 GM151568NIGMS NIH HHS R35 GM150970
6 · The paper itself

Abstract

Hydrogels have been used in the clinic since the late 1980s with broad applications in drug delivery, cosmetics, tissue regeneration, among many other areas. The past three decades have witnessed rapid advances in the fields of polymer chemistry, crosslinking approaches, and hydrogel fabrication methods, which have collectively brought many new hydrogel products, either injectable or non-injectable, to clinical studies. In an article published in 2020 entitled "Hydrogels in the clinic", we reviewed the clinical landscape and translational challenges of injectable hydrogels. Here, we provide an update on the advances in the field and also extend the scope to include non-injectable hydrogels. We highlight recently approved hydrogel products, provide an update on the clinical trials of injectable hydrogels, and discuss active clinical trials of topically applied and implantable hydrogels.

Indexed as

clinicclinical translationclinical trialscrosslinkingdrug deliveryhydrogelinjectable materialstissue engineeringtranslational medicine

Identifiers

PMID39545079
PMCPMC11558196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.